DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Ubicación actual:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Cardiology Homepage

Algorithm steers catheters to the right spot to treat atrial fibrillation

Noninvasive biomarker for Parkinson's disease possibly found in EEG data

MaxQ AI launches ACCIPIO Ax, slice-level intracranial hemorrhage (ICH) detection and preview in the US and EU

SCAI and ACVP release consensus statement on cardiovascular catheterization laboratory economics

SCAI releases multi-society endorsed consensus on the classification stages of cardiogenic shock

Dale introduces new hold-n-place catheter securement products

Philips launches new IntraSight interventional applications platform to integrate intravascular imaging and physiology

RIA Endovascular Clinic opens first interventional suite in Denver metro area

Intelligent data analytics software solution comes to electrophysiology with launch of Biosense Webster's CARTONET

Data suggests new guidelines in stroke care have led to record numbers of patients treated

iSchemaView’s RAPID approved for use in the Kingdom of Saudi Arabia

Press releases may be edited for formatting or style
MENLO PARK, Calif.--(BUSINESS WIRE)--iSchemaView, the worldwide leader in advanced imaging for stroke, has received approval from the Kingdom of Saudi Arabia’s Ministry of Health (MOH), for the use of the RAPID imaging platform across the Kingdom of Saudi Arabia. RAPID is designed to provide physicians with fast, fully automated, and easy-to-interpret imaging that facilitates clinical decision-making around stroke.

Hospitals and clinics that treat ischemic stroke in the Kingdom of Saudi Arabia will now have access to RAPID’s automated CTP, MR, CTA and ASPECTS solutions, as well as their unique mobile app that accelerates the provision of information to support treatment decision making. RAPID’s expansion into Saudi Arabia represents continued market growth across the Middle East and is further confirmation that RAPID has become the de facto standard for stoke imaging around the world.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



“With RAPID’s AI framework and advanced imaging technology we aim to help increase the number of patients that can be successfully treated for stroke within the Kingdom of Saudi Arabia,” said Simon Canham, iSchemaView Vice President & General Manager EMEA. “Moving forward the country's physicians will be able to aide performance by making life-saving decisions faster and more easily, improving patient outcomes and lives.”

Developed by leading stroke experts, RAPID technology has been selected for use in several ground-breaking trials that have changed treatment guidelines issued by both the American Heart Association and American Stroke Association. The RAPID Artificial Intelligence framework combines deep learning, machine learning and expert feature extraction. Together these provide unparalleled sensitivity and specificity across stroke modules (CT perfusion, MR diffusion and perfusion, CTA and CT ASPECT scoring). Results are then delivered by the RAPID Intelligence Services Platform via PACS, email, SMS/MMS, the RAPID app or corporate partner workflow systems.

Unique in the comprehensive depth and range of its clinical validation, RAPID is now also the imaging standard in stroke research. iSchemaView’s imaging solution now has a research footprint across more than 300 stroke centers and more than 10 large-scale international clinical trials. RAPID has been shown to aid in the selection of patients in early and late-window stroke trials, including SWIFT PRIME, EXTEND IA, DAWN, DEFUSE 3 and EXTEND, and has been granted FDA clearance for selection of patients for both early and late window thrombectomy.
  Pages: 1 - 2 >>

Cardiology Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Directorio
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Trabajos/Entrenamiento
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Certificado recientemente
Ver usuarios certificados recientemente
Recientemente clasificado
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Mantenga el foro de los técnicos
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2019 DOTmed.com, Inc.
TODOS LOS DERECHOS RESERVADOS